Maher Albitar, MD
Dr. Maher Albitar is a professor in the Department of Oncology of the Hackensack Meridian School of Medicine and the founder, Chief Executive Officer and Chief Medical Officer of Genomic Testing Cooperative, LCA. Dr. Albitar has extensive experience in anatomic/clinical pathology, hematopathology and molecular pathology. Until 2018, Dr. Albitar was the Senior Vice President, Chief Medical Officer and Director of Research and Development at NeoGenomics Laboratories. Prior to NeoGenomics, Dr. Albitar served as the Medical Director and Chief R&D for Hematopathology and Oncology, Nichols Institute, Quest Diagnostics from 2003 to 2010. From 1991 to 2003, Dr. Albitar held various faculty positions at the University of Texas MD Anderson Cancer Center, including Chief of Leukemia Section in Laboratory Medicine and Pathology Department, Director of the molecular laboratory and Director of Hematopathology Fellowship program.
Dr. Albitar was a tenured full professor in Pathology and Leukemia at the time of leaving MD Anderson Cancer Center. Dr. Albitar residency in AP/CP pathologist was at Brown University in Providence, Rhode Island and fellowship training in Hematopathology at the University of Pennsylvania. After his training in Hematopthology, Dr. Albitar spend 4 years in NIH sponsored Physician/Scientist training program at the University of Pennsylvania/Howard Hughes Medical Institute and the Department of Genetics. Dr. Albitar has published more than 300 peer-reviewed papers, book chapters, and review articles. He is the lead inventor on more than 60 different patents and patent applications. He is a well-recognized leader in molecular and genomic diagnosis research and development.